Navigation Links
New research effort into causes of chronic fatigue syndrome
Date:9/27/2011

September 27, 2011 --The Chronic Fatigue Initiative (CFI) a new privately funded research directive focused on chronic fatigue syndrome announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.

Chronic fatigue syndrome is a condition believed to affect about 1million Americans. It is characterized by symptoms similar to those of common viral infections and can include muscle aches, headache and extreme fatigue. Its cause is unknown, and currently there is no cure.

Established by a donation of more than $10 million from the Hutchins Family Foundation, the Chronic Fatigue Initiative will bring together medical experts from the world's leading research institutions, including Columbia, Harvard, Stanford and Duke Universities. The Initiative's initial phase of funding includes support for pathogenesis research at the Center for Infection and Immunity, and for NewYork-Presbyterian Hospital/Columbia University Medical Center, where it will establish the Hutchins Family Fellowship in Infectious Disease under the direction of Dr. Scott Hammer, professor of epidemiology and chief of the Division of Infectious Diseases at NewYork-Presbyterian/Columbia.

"Dr. Hornig was the prime mover in designing the research plan and will be shepherding the CFI's research at the Center for Infection and Immunity," said Dr. Lipkin, the director of CII.

Dr. Hornig, an associate professor of epidemiology at the Mailman School of Public Health and director of Translational Research at CII, will direct research on biomarkers and pathogen discovery for the Chronic Fatigue Initiative. The research will focus on characterizing the causes of this enigmatic disorder.

Scientists will examine samples from 200 patients and controls using state-of-the-art molecular techniques pioneered at CII. Patients will be recruited across the country from five clinical sites that specialize in chronic fatigue syndrome.

During the first part of the project, they will screen for already known pathogens thought to be associated with the disease. Then they will use unbiased genetic sequencing to help them identify any novel pathogens. CII scientists will also look at patients' host response profiles the immune molecule and antibody signatures in their peripheral blood samples. This will enable researchers to get a comprehensive picture of what is happening in individual patients in relation to pathogens to which they may have been exposed and could lead to the identification of biomarkers for CFS.

Drs. Lipkin and Hornig will also collaborate with Dr. Scott M. Hammer and the inaugural Hutchins Family Fellow for Infectious Disease at NewYork-Presbyterian/Columbia Dr. Claire Gordon.

"This is a truly exciting opportunity to understand the causes of this often neglected disorder," said Dr. Hornig. "We hope our findings will lead to better diagnoses and the development of an effective treatment."


'/>"/>

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
(Date:6/23/2016)... 23, 2016 Leading BioSciences Inc., a ... conditions resulting from a breakdown of the mucosal ... Greg Doyle as chief executive officer. Mr. ... management team and board of directors, previously served ... He will provide continued leadership and strategic direction ...
Breaking Medicine Technology: